Paloma Partners’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Paloma Partners’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-21,683	Closed	-$129K	–	1882
2022 Q1	$174K	Buy	21,683 +2,318	+12%	+$20.4K	0.01%	1449
2021 Q4	$225K	Buy	+19,365	New	+$232K	﹤0.01%	1548

Other funds holding SLGC

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MAM

Madryn Asset Management New York $34.1M AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Paloma Partners's SLGC Position: Q2 2022 in Review

Paloma Partners sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q2 2022, closing a stake of 21,683 shares — an estimated $129K sold.

Paloma Partners first reported a position in SLGC in Q4 2021 and held it in 2 quarters. The position peaked at $225K in Q4 2021. 135 funds tracked by Wall St. Rank hold SLGC as of Q2 2022.

Paloma Partners reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Paloma Partners sold 21,683 SomaLogic, Inc. Class A Common Stock shares in Q2 2022, an estimated $129K.
Paloma Partners first reported a position in SomaLogic, Inc. Class A Common Stock in Q4 2021 and held it in 2 quarters.
Paloma Partners's SomaLogic, Inc. Class A Common Stock position peaked at $225K in Q4 2021.
135 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q2 2022.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.